Title : The effect of colchicine on mortality outcome and duration of hospital stay in patients with COVID-19: A meta-analysis of randomized trials.

Pub. Date : 2022 Feb

PMID : 34970856






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The NLRP3 inhibitor, colchicine, therefore, appears to be promising for the treatment of COVID-19. Colchicine NLR family pyrin domain containing 3 Homo sapiens
2 DISCUSSION AND CONCLUSION: The ability of colchicine to reduce the length of stay in hospitalized patients with COVID-19 is consistent with its potential to prevent clinical deterioration via inhibition of NLRP3 inflammasome. Colchicine NLR family pyrin domain containing 3 Homo sapiens